Stability of magistral phage preparations before therapeutic application in patients with chronic rhinosinusitis, sepsis, pulmonary, and musculoskeletal infections

MLA

Saartje Uyttebroek, et al. “Stability of Magistral Phage Preparations before Therapeutic Application in Patients with Chronic Rhinosinusitis, Sepsis, Pulmonary, and Musculoskeletal Infections.” Microbiology Spectrum, vol. 11, no. 6, Dec. 2023. EBSCOhost, https://doi.org/10.1128/spectrum.02907-23.

APA

Saartje Uyttebroek, Laura Bessems, Willem-Jan Metsemakers, Yves Debaveye, Laura Van Gerven, Lieven Dupont, Melissa Depypere, Jeroen Wagemans, Rob Lavigne, Maya Merabishvili, Jean-Paul Pirnay, David Devolder, Isabel Spriet, & Jolien Onsea. (2023). Stability of magistral phage preparations before therapeutic application in patients with chronic rhinosinusitis, sepsis, pulmonary, and musculoskeletal infections. Microbiology Spectrum, 11(6). https://doi.org/10.1128/spectrum.02907-23

Chicago

Saartje Uyttebroek, Laura Bessems, Willem-Jan Metsemakers, Yves Debaveye, Laura Van Gerven, Lieven Dupont, Melissa Depypere, et al. 2023. “Stability of Magistral Phage Preparations before Therapeutic Application in Patients with Chronic Rhinosinusitis, Sepsis, Pulmonary, and Musculoskeletal Infections.” Microbiology Spectrum 11 (6). doi:10.1128/spectrum.02907-23.